|
Chemical Name: Methylphenidate hydrochloride Brand Name: Ritalin (available in generic) Manufacturer: Novartis Pharmaceuticals Description: A mild CNS (central nervous system) stimulant that presumably activates the brain stem arousal system and cortex to produce its stimulant effect. There is no clear evidence that establishes the mechanism by which Ritalin produces its mental and behavioral effects on children. Indications and Usage: For attention deficit disorders and narcolepsy. Contraindications, Warnings, and Precautions: Marked anxiety, tension, and agitation are contraindications to Ritalin since the drug may aggravate these symptoms. Also contraindicated in patients with glaucoma and in patients with motor tics or a family history or diagnosis of Tourette's Syndrome. Suppression of growth has been reported with the long term use of stimulant medications in children. There is some clinical evidence that Ritalin may lower the convulsive threshold in patients with prior history of seizures. Do not use together or within fourteen days of the discontinuation of a MAOI (monoamine oxidase inhibitor). Adverse Reactions: Possible common reported side effects include nervousness, insomnia and tachycardia. Less common side effects include headache, dry throat, nausea, decreased appetite and weight loss. There have been rare reports of Tourette's Syndrome. Overdosage: Signs and symptoms may include vomiting, agitation, tremors, hyperreflexia, muscle twitching, convulsions, euphoria, confusion, hallucinations, flushing, headache and palpitations. Emergency treatment is recommended immediately. Dosing Range: Dosing varies greatly according to weight, age and responsiveness to the medication. Daily doses above 60mg are not recommended. Doses should be divided two to three times per day, preferably thirty to forty-five minutes before meals.
|
|
These pages are solely for public informational purposes. The information cannot be relied on to make diagnoses or prescribe treatment in any individual. Persons who require such services should consult with a licensed professional. Send mail to ropa@redoakpsychiatry.com with questions or comments about this web site.© 2000 Red Oak Psychiatry Associates, P.A. Updated
11/26/2007
|